Diabetes Treatments, What We’re Talking About This Week

1.  The riskiest drugs to develop? Diabetes treatments, says Tufts report

While the demand for new diabetes therapies grows, the development of endocrine drugs is riskier than all other drug development, according to a study conducted by the Tufts Center for the Study of Drug Development.

2.  Adverse Effects Underreported in Clinical Trials

A recent report discusses the growing concerns about the negative impact erroneous clinical trial reporting can have on treatment and cures.

3.  Combo gene and chemotherapy could prevent breast cancer metastasis

Another step toward the progress of finding a cure for breast cancer! A combination of gene therapy along with chemotherapy may slow breast cancer metastasis.